HLS Therapeutics Sees FY2026 Sales $56.000M-$60.000M vs $57.730M Est

Benzinga · 1d ago
HLS Therapeutics (TSX:HLS) sees FY2026 sales of $56.000 million-$60.000 million vs $57.730 million analyst estimate.